Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
The Ravulizumab in Atypical Haemolytic Uraemic Syndrome Adis Drug Evaluation video abstract, script and image slide deck provide a brief overview of the mechanism of action of ravulizumab in atypical haemolytic uraemic syndrome, the administration regimen and the key efficacy and tolerability outcomes from clinical trials.
The video abstract, script and slide deck, which have been peer reviewed and were uploaded to Figshare after the Ravulizumab in Atypical Haemolytic Uraemic Syndrome Adis Drug Evaluation was published, are sponsored by Alexion Pharmaceuticals, Inc.
The video abstract can be found here.
© Springer Nature Switzerland AG 2021